Status:
COMPLETED
Hepatocellular Carcinoma Registry for Turkey (3K Trial)
Lead Sponsor:
Bayer
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the g...
Eligibility Criteria
Inclusion
- To be diagnosed with hepatocellular carcinoma in last 3 months
- To be older than 18 years old
- To sign informed consent form (ICF)
Exclusion
- Patients that does not sign or withdraw informed consent form.
- According to investigator's opinion; existence of any situation/condition that will significantly complicate patient follow up.
- Currently or previously taking part in 3K observational study
Key Trial Info
Start Date :
August 13 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 12 2018
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01473121
Start Date
August 13 2012
End Date
July 12 2018
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Turkey (Türkiye)